Navigation Links
CuraGen Reports Third Quarter 2007 Financial Results
Date:10/25/2007

"will," "will enable," "would be expected," "look forward," "may provide," "would" or similar terms, variations of such terms or the negative of those terms. Such forward-looking statements involve known and unknown risks, uncertainties and other factors including the risk that any one or more of CuraGen's drug development programs will not proceed as planned for technical, scientific or commercial reasons or due to patient enrollment issues or based on new information from nonclinical or clinical studies or from other sources, the success of competing products and technologies, CuraGen's stage of development as a biopharmaceutical company, government regulation and healthcare reform, technological uncertainty and product development risks, product liability exposure, uncertainty of additional funding, CuraGen's history of incurring losses and the uncertainty of achieving profitability, reliance on research collaborations and strategic alliances, competition, patent infringement claims against CuraGen's products, processes and technologies, CuraGen's ability to protect its patents and proprietary rights and uncertainties relating to commercialization rights, as well as those risks, uncertainties and factors referred to in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2007, filed with the Securities and Exchange Commission under the section "Risk Factors," as well as other documents that may be filed by CuraGen from time to time with the Securities and Exchange Commission. As a result of such risks, uncertainties and factors, the Company's actual results may differ materially from any future results, performance or achievements discussed in or implied by the forward-looking statements contained herein. CuraGen is providing the information in this press release as of this date and assumes no obligations to update the information included in this press release or revise any forward-looking statements, whether as a result of new information
'/>"/>
SOURCE CuraGen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Autopsy reports could be valuable and informative
2. China reports declining number of SARS Cases
3. Russia Reports First SARS Case
4. Research reports that c-section deliveries are rising
5. Jharkhand reports 13,000 Malaria cases
6. Uganda Reports Failure To Contain Sleeping Sickness
7. WHO reports 36 million deaths world wide due to chronic diseases
8. Reports of Hantavirus infection in India raise concerns
9. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
10. China Reports Yet Another Bird Flu Case
11. China reports seventh bird flu victim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Spider Veins and Telangiectasia , ... (PRWEB) December 10, 2009 -- Millions ... telangiectasia – those unsightly clusters of red, blue or purple veins ... for Western populations like the US, it’s been estimated that 25-30% of ... , , , ,Although the Veinwave has been available for ...
(Date:12/15/2009)... Ill. A study in the Dec. 15 ... Medicine indicates that significant associations exist between ... regurgitation and headaches in young school-aged children. ... parent-reported insomnia was 3.3 times more likely in ... likely in children with headaches. Nineteen percent ...
(Date:12/14/2009)... synthetic red-blood-cell-like particles carry oxygen, drugs, and more… , ... ... at UC Santa Barbara, in collaboration with scientists at University ... characteristics and key functions of natural red blood cells, including ... , , , ,The primary function of natural red blood ...
(Date:12/14/2009)... Trust ("Americold") announced today that it has filed a ... and Exchange Commission (the "SEC") relating to a proposed ... of shares to be offered and the price range ... common shares to be sold in this offering are ... joint book-running managers of the offering will be Goldman, ...
(Date:12/14/2009)... 14 The National Organization for Rare Disorders ... end to lifetime and annual health insurance caps. ... a newspaper distributed widely on Capitol Hill, NORD said ... would allow caps to continue for most Americans, contrary ... health care reform and welcomes the promises made by ...
Breaking Medicine News(10 mins):Health News:Vein Center & CosMed, Inc. Selected as Exclusive St. Louis Provider of FDA-Cleared Device 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 3Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering 2Health News:NORD Calls for Immediate End to Lifetime Insurance Caps 2
... Ohio More than three-quarters of young violent offenders interviewed ... die in a violent incident, a new study reveals. , ... and 78 percent said they had a close friend who ... lifelong exposure to violence may lead some inner-city youth to ...
... Four Dogs Die of CancerCancer is the Number One Cause of Death ... DogsDENVER, Jan. 13 Dog owners and lovers in the ... beloved pets. They are correct. One in four ... in dogs over the age of 2. Morris Animal Foundation ...
... Recession, Winter Weather Compound January,s Blood Drain NEW YORK, ... its regional operations (serving New York City, Long Island, ... appeal for blood donations. Hospital demand for blood ... seasonal expectations while levels of blood donation have been ...
... OTTAWA , Jan. 13 /PRNewswire/ - Researchers at the ... successfully grown blood vessels in damaged muscle tissue by ... and support regeneration. Blood vessel regeneration suggests that the ... repair heart damage and restore function. , Details of ...
... that you have just arrived,on your night shift and you ... Of those, two speak only Spanish. You note ... gathered,around the patient,s door and they appear alarmed. There ... and the hospital medical staff try, in vain,to communicate. , ...
... the University of Liverpool have developed a new dental product ... visible to the human eye. , The toothbrush-sized product has ... the mouth and viewed through yellow glasses with a red ... glow. The device, produced in collaboration with dental and healthcare ...
Other Medicine News:Health News:Study: Most young violent offenders in two NYC neighborhoods have seen someone killed 2Health News:Study: Most young violent offenders in two NYC neighborhoods have seen someone killed 3Health News:Study: Most young violent offenders in two NYC neighborhoods have seen someone killed 4Health News:Canine Cancer #1 Fear of Dog Lovers, Web Exclusive by Morris Animal Foundation Provides News on Latest Breakthroughs - Crucial Facts for Dog Owners 2Health News:Canine Cancer #1 Fear of Dog Lovers, Web Exclusive by Morris Animal Foundation Provides News on Latest Breakthroughs - Crucial Facts for Dog Owners 3Health News:Blood Emergency: Blood Supply Tips Into Danger Zone 2Health News:Blood Emergency: Blood Supply Tips Into Danger Zone 3Health News:Blood Emergency: Blood Supply Tips Into Danger Zone 4Health News:Blood Emergency: Blood Supply Tips Into Danger Zone 5Health News:University of Ottawa Heart Institute Scientists Successfully Develop Novel Biomaterial to Help Grow New Blood Vessels 2Health News:University of Ottawa Heart Institute Scientists Successfully Develop Novel Biomaterial to Help Grow New Blood Vessels 3Health News:Command Spanish Online offers Healthcare Spanish Anytime, Anywhere, and at Your Own Pace 2
(Date:12/14/2009)... Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT ... Notice of Allowance from the United States Patent ... patent application no. 11/060,641, which covers the composition ... sublingual tablet), the lead Transcept product candidate. ... than February 2025. ,, "This is the second ...
(Date:12/14/2009)... In response to an FDA ... which the Agency recommended that healthcare facilities discontinue ... processing system, hospitals throughout the U.S. are faced ... that product. According to the FDA, STERIS made ... may affect the safety or the effectiveness of ...
(Date:12/14/2009)... 14 The board of directors of Eli ... declared a dividend for the first quarter of 2010 ... ,, The dividend is payable March 10, 2010 ... on ,, February 12, 2010. ,, Lilly, a ... pharmaceutical products by applying the latest research from its ...
Breaking Medicine Technology:Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 2Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 3Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 4ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 2ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 3Spread your sperm the smart way 9186 1Spread your sperm the smart way 9186 2Spread your sperm the smart way 9186 3Pioneer of Digital Place Based Media Joins World 26apos 3Bs Leading Blood Pressure and Health Kiosk Manufacturer 51199 1Pioneer of Digital Place Based Media Joins World 26apos 3Bs Leading Blood Pressure and Health Kiosk Manufacturer 51199 2Microbix Files First Patent Applications On Novel Technology Platform For Large Semen Sexing Market 12957 1Microbix Files First Patent Applications On Novel Technology Platform For Large Semen Sexing Market 12957 2
... centers to collaborate on studies of immunosuppression ... immunity, COLUMBIA, Md., Aug. 28 "Cylex, Inc., ... delighted to be able to,announce our support for a ... at seven highly respected medical institutions,in the Republic of ...
... Tonight in Parts of Bucks, Delaware, Montgomery,Philadelphia Counties, ... following the first night of aerial treatments, the ... evening to protect,the public against the mosquito-borne West ... administered between 8 p.m. and,midnight in portions of ...
Other Medicine Technology:Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea 2Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea 3DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 2DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 3
Latex agglutination slide test for the qualitative and quantitative determination of Rheumatoid Factor in serum....
Hemagglutination slide test for the qualitative and quantitative detection of infectious mononucleosis heterophile antibodies in serum or plasma....
Latex agglutination slide test for the qualitative detection of C-Reactive Protein in serum....
... Medical Professional Diagnostics is a leading provider ... and DFA test menu that includes kits ... as well as miscellaneous conjugates and components. ... a wide assortment of substrates and kit ...
Medicine Products: